| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| OTLK Outlook Therapeutics Inc | 47,229,110.0 | 57,785,810.0 | 59,028,670.0 |
| UBX UNITY Biotechnology Inc | 7,430,000.0 | 38,519,000.0 | 58,863,000.0 |
| LPTX Leap Therapeutics Inc | 54,921,000.0 | 56,185,000.0 | 57,963,000.0 |
| RANI Rani Therapeutics Holdings Inc | 5,864,000.0 | 50,847,000.0 | 57,916,000.0 |
| VTVT vTv Therapeutics Inc | 52,255,000.0 | 53,872,000.0 | 54,183,000.0 |
| CDXC Chromadex Corp | 27,413,000.0 | 48,976,000.0 | 54,079,000.0 |
| CUE Cue Biopharma Inc | 41,029,000.0 | 44,669,000.0 | 53,951,000.0 |
| KALA KALA BIO Inc | 48,478,000.0 | 50,087,000.0 | 53,033,000.0 |
| CDTX Cidara Therapeutics Inc | 29,018,000.0 | 46,834,000.0 | 52,716,000.0 |
| XAIR Beyond Air Inc | 7,971,000.0 | 39,439,000.0 | 51,911,000.0 |
| OCUP Ocuphire Pharma Inc | 47,161,000.0 | 51,844,000.0 | 51,844,000.0 |
| OCGN Ocugen Inc | 26,375,000.0 | 29,998,000.0 | 51,794,000.0 |
| CAPR Capricor Therapeutics Inc | 6,214,650.0 | 41,411,920.0 | 49,444,440.0 |
| DMAC DiaMedica Therapeutics Inc | 2,097,000.0 | 47,484,000.0 | 49,260,000.0 |
| PRTG Portage Biotech Inc | 5,341,000.0 | 7,516,000.0 | 49,035,000.0 |
| INMB INmune Bio Inc | 26,002,000.0 | 29,824,000.0 | 46,833,000.0 |
| EVGN Evogene Ltd | 11,915,000.0 | 31,022,000.0 | 46,780,000.0 |
| CLNN Clene Inc. | 21,732,000.0 | 32,111,000.0 | 45,069,000.0 |
| EQ Equillium Inc | 11,568,000.0 | 42,480,000.0 | 43,597,000.0 |
| CLRB Cellectar Biosciences Inc | 40,031,180.0 | 41,368,370.0 | 42,908,440.0 |
| CLSD Clearside Biomedical Inc | 35,355,000.0 | 36,115,000.0 | 40,142,000.0 |
| CRVS Corvus Pharmaceuticals Inc | 7,456,000.0 | 22,851,000.0 | 40,084,000.0 |
| PPBT Purple Biotech Ltd | 9,985,000.0 | 11,402,000.0 | 39,863,000.0 |
| LTRN Lantern Pharma Inc | 18,357,940.0 | 39,470,860.0 | 39,734,220.0 |
| CGTX Cognition Therapeutics Inc | 34,671,000.0 | 37,968,000.0 | 38,851,000.0 |
| ABIO ARCA Biopharma Inc | 35,903,000.0 | 36,670,000.0 | 36,706,000.0 |
| SYBX Synlogic Inc | 24,822,000.0 | 34,946,000.0 | 36,057,000.0 |
| IMMX Immix Biopharma Inc | 29,319,230.0 | 32,915,260.0 | 34,347,590.0 |
| APRE Aprea Therapeutics Inc | 32,369,970.0 | 33,068,840.0 | 33,200,010.0 |
| GLTO Galecto Inc | 21,091,000.0 | 30,541,000.0 | 32,477,000.0 |
| FBRX Forte Biosciences Inc | 30,444,000.0 | 31,502,000.0 | 32,017,000.0 |
| SBFM Sunshine Biopharma Inc | 17,434,210.0 | 28,831,220.0 | 31,898,720.0 |
| AEZS Aeterna Zentaris Inc | 29,545,000.0 | 31,195,000.0 | 31,792,000.0 |
| CADL Candel Therapeutics Inc | 25,713,000.0 | 27,136,000.0 | 31,217,000.0 |
| TRVN Trevena Inc | 23,552,000.0 | 25,978,000.0 | 31,137,000.0 |
| NCNA NuCana PLC | 16,150,626.8 | 27,674,955.0 | 31,127,735.1 |
| ORGS Orgenesis Inc | 80,000.0 | 1,956,000.0 | 30,920,000.0 |
| MBRX Moleculin Biotech Inc | 16,824,000.0 | 18,957,000.0 | 30,845,000.0 |
| ETON Eton Pharmaceuticals Inc | 16,655,000.0 | 24,263,000.0 | 30,794,000.0 |
| HCWB HCW Biologics Inc | 4,084,080.0 | 6,208,650.0 | 30,427,660.0 |
| PULM Pulmatrix Inc | 16,300,000.0 | 17,582,000.0 | 30,391,000.0 |
| CLGN Collplant Biotechnologies Ltd | 23,225,000.0 | 24,478,000.0 | 30,293,000.0 |
| WINT Windtree Therapeutics Inc | 2,547,000.0 | 3,339,000.0 | 30,103,000.0 |
| PIRS Pieris Pharmaceuticals Inc | 19,084,000.0 | 29,497,000.0 | 29,497,000.0 |
| SNPX Synaptogenix Inc | 26,329,960.0 | 28,828,340.0 | 29,399,250.0 |
| LUMO Lumos Pharma Inc | 23,179,000.0 | 27,544,000.0 | 28,078,000.0 |
| EFTR eFFECTOR Therapeutics Inc | 15,508,000.0 | 26,250,000.0 | 27,131,000.0 |
| COCP Cocrystal Pharma Inc | 21,842,000.0 | 24,492,000.0 | 26,546,000.0 |
| EYEN Eyenovia Inc | 7,976,110.0 | 14,451,090.0 | 26,177,160.0 |
| ONCY Oncolytics Biotech Inc | 1,744,531.6 | 24,582,504.8 | 25,589,900.0 |
| INAB IN8BIO, Inc. | 13,015,000.0 | 15,755,000.0 | 25,549,000.0 |
| GNTA Genenta Science SPA | 4,074,146.43 | 23,460,109.04 | 24,664,102.51 |
| BFRI Biofrontera Inc | 3,817,000.0 | 20,155,000.0 | 24,575,000.0 |
| SLS Sellas Life Sciences Group Inc | 18,415,000.0 | 21,501,000.0 | 24,434,000.0 |
| FEMY Femasys Inc | 17,835,970.0 | 19,883,330.0 | 24,370,960.0 |
| ANIX Anixa Biosciences Inc | 995,000.0 | 24,214,000.0 | 24,355,000.0 |
| KTTA Pasithea Therapeutics Corp | 12,009,350.0 | 13,192,900.0 | 22,408,100.0 |
| NVCT Nuvectis Pharma Inc | 19,464,000.0 | 19,714,000.0 | 19,714,000.0 |
| INVO INVO Bioscience Inc | 475,130.0 | 1,724,950.0 | 18,317,770.0 |
| CMMB Chemomab Therapeutics Ltd | 4,665,000.0 | 16,837,000.0 | 18,009,000.0 |
| APVO Aptevo Therapeutics Inc | 10,250,000.0 | 12,074,000.0 | 17,629,000.0 |
| NRBO NeuroBo Pharmaceuticals Inc | 15,988,000.0 | 16,764,000.0 | 17,018,000.0 |
| HEPA Hepion Pharmaceuticals Inc | 13,105,500.0 | 15,430,370.0 | 15,989,410.0 |
| MYNZ Mainz Biomed NV | 7,070,930.0 | 8,979,790.0 | 15,409,030.0 |
| ATHE Alterity Therapeutics Ltd | 8,382,327.75 | 14,963,198.3 | 15,098,916.51 |
| BNTC Benitec Biopharma Inc | 14,143,000.0 | 14,366,000.0 | 14,999,000.0 |
| REVB Revelation Biosciences Inc | 14,551,740.0 | 14,623,620.0 | 14,701,610.0 |
| MBIO Mustang Bio Inc | 1,337,000.0 | 9,240,000.0 | 14,592,000.0 |
| ABVC ABVC Biopharma Inc | 60,160.0 | 1,656,710.0 | 14,492,600.0 |
| TENX Tenax Therapeutics Inc | 12,549,480.0 | 14,459,150.0 | 14,460,260.0 |
| DARE Dare Bioscience Inc | 3,630,600.0 | 9,982,560.0 | 13,012,720.0 |
| APTO Aptose Biosciences Inc | 7,346,000.0 | 11,821,000.0 | 12,796,000.0 |
| DYAI Dyadic International Inc | 10,569,810.0 | 12,541,310.0 | 12,681,270.0 |
| PALI Palisade Bio Inc | 11,276,000.0 | 12,013,000.0 | 12,652,000.0 |
| BRTX BioRestorative Therapies Inc | 884,380.0 | 11,390,530.0 | 12,611,720.0 |
| GNPX Genprex Inc | 8,217,120.0 | 9,227,880.0 | 12,564,590.0 |
| BCTX Briacell Therapeutics Corp | 6,244,530.0 | 11,741,960.0 | 12,231,050.0 |
| CKPT Checkpoint Therapeutics Inc | 11,241,000.0 | 11,975,000.0 | 11,975,000.0 |
| ALLR Allarity Therapeutics Inc | 312,000.0 | 2,295,000.0 | 11,969,000.0 |
| XCUR Exicure Inc | 816,000.0 | 2,024,000.0 | 11,580,000.0 |
| CYCN Cyclerion Therapeutics Inc | 5,696,000.0 | 6,014,000.0 | 11,364,000.0 |
| VINC Vincerx Pharma Inc | 5,110,000.0 | 7,677,000.0 | 11,083,000.0 |
| CELZ Creative Medical Technology Holdings Inc | 3,466,870.0 | 10,270,900.0 | 10,715,190.0 |
| ARTL Artelo Biosciences Inc | 1,195,000.0 | 8,188,000.0 | 10,354,000.0 |
| ENTX Entera Bio Ltd | 9,189,000.0 | 9,751,000.0 | 10,239,000.0 |
| THMO Thermogenesis Holdings Inc | 1,176,000.0 | 4,351,000.0 | 10,087,000.0 |
| GTBP GT Biopharma Inc | 1,950,000.0 | 9,885,000.0 | 9,912,000.0 |
| LGVN Longeveron Inc | 1,940,000.0 | 3,757,000.0 | 9,697,000.0 |
| TCON TRACON Pharmaceuticals Inc | 7,891,000.0 | 8,402,000.0 | 9,355,000.0 |
| TFFP TFF Pharmaceuticals Inc | 3,211,930.0 | 4,862,520.0 | 9,186,550.0 |
| TCBP TC BioPharm Ltd | 1,231,202.9 | 5,274,909.18 | 9,117,109.16 |
| ACXP Acurx Pharmaceuticals Inc | 8,920,930.0 | 9,108,830.0 | 9,108,830.0 |
| NEXI Neximmune Inc | 4,452,900.0 | 6,042,020.0 | 8,990,610.0 |
| MNPR Monopar Therapeutics Inc | 7,807,580.0 | 8,912,300.0 | 8,912,300.0 |
| ENVB Enveric Biosciences Inc | 6,356,040.0 | 8,228,820.0 | 8,849,790.0 |
| HOTH Hoth Therapeutics Inc | 7,562,630.0 | 8,406,290.0 | 8,491,330.0 |
| SNGX Soligenix Inc | 7,091,550.0 | 7,818,390.0 | 8,058,390.0 |
| EDSA Edesa Biotech Inc | 4,267,790.0 | 5,416,260.0 | 7,831,790.0 |
| ANVS Annovis Bio Inc | 3,136,970.0 | 7,813,300.0 | 7,813,300.0 |
| KTRA Kintara Therapeutics Inc | 6,351,000.0 | 6,755,000.0 | 7,446,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例